Kister I, Patskovsky Y, Curtin R, Pei J, et al. Cellular and humoral immunity to SARS-CoV-2 infection in multiple sclerosis patients on ocrelizumab and other disease-modifying therapies: a multi-ethnic observational study. Ann Neurol 2022 Mar 15. doi: 10.1002/ana.26346.
PMID: 35289960